Table 2.
Baseline and 3 month outcomes (N = 76)
| Variable | High‐protein group (n = 33) | Standard‐protein group (n = 43) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline (mean ± SD) | 3 month (mean ± SD) | △ | %△ | Baseline (mean ± SD) | 3 month (mean ± SD) | △ | %△ | P (time) | P (T × G) | |
| Weight (lb) | 105.5 ± 22.4 | 101.9 ± 21.7 | −3.6 | 3.4 | 109.9 ± 19.3 | 106.9 ± 18.2 | −3.0 | 2.7 | 0.000 | 0.383 |
| Body mass index (kg/m2) | 36.2 ± 7.1 | 34.7 ± 6.9 | −1.5 | 4.3 | 37.3 ± 5.4 | 36.3 ± 5.3 | −1.0 | 2.8 | 0.000 | 0.067 |
| Waist circumference (cm) | 46.9 ± 6.2 | 45.0 ± 6.2 | −1.9 | 4.0 | 47.9 ± 4.5 | 46.6 ± 4.3 | −1.3 | 2.8 | 0.000 | 0.364 |
| Total cholesterol (mg/dL) | 160.2 ± 41.9 | 143.4 ± 33.2 | −16.8 | 11.7 | 163.7 ± 39.3 | 162.8 ± 44.5 | −0.9 | 0.6 | 0.017 | 0.031 |
| LDL cholesterol (mg/dL) | 85.5 ± 32.2 | 83.0 ± 33.1 | −2.5 | 3.0 | 94.0 ± 32.4 | 92.9 ± 39.9 | −1.1 | 1.2 | 0.552 | 0.811 |
| HDL cholesterol (mg/dL) | 37.9 ± 10.6 | 38.8 ± 9.5 | 0.9 | 2.3 | 40.0 ± 9.2 | 40.9 ± 8.2 | 0.9 | 2.2 | 0.094 | 0.926 |
| Triglycerides (mg/dL) | 163.2 ± 59.2 | 137.5 ± 54.8 | −25.7 | 18.7 | 154.0 ± 65.1 | 148.3 ± 53.6 | −5.7 | 3.8 | 0.001 | 0.032 |
| HgbA1c (%) | 7.2 ± 1.3 | 6.5 ± 1.0 | −0.7 | 10.8 | 7.3 ± 1.8 | 7.2 ± 1.6 | −0.1 | 1.4 | 0.000 | 0.002 |
| Systolic BP (mmHg) | 123.3 ± 12.8 | 112.5 ± 11.8 | −10.8 | 9.6 | 116.8 ± 19.5 | 117.5 ± 15.7 | 0.7 | 0.9 | 0.001 | 0.000 |
| Diastolic BP (mmHg) | 72.8 ± 9.6 | 65.2 ± 8.1 | −7.6 | 11.7 | 73.30 ± 1.0 | 70.1 ± 6.9 | −3.2 | 4.6 | 0.000 | 0.040 |
BP, blood pressure; HDL, high‐density lipoprotein; HgbA1c, glycosylated haemoglobin; LDL, low‐density lipoprotein; SD, standard deviation.